Dermatologic disorders in transgender patients: A retrospective cohort of 442 patients - 10/10/20
Doi : 10.1016/j.jaad.2020.06.074
Reese L. Imhof, BA a, Caroline J. Davidge-Pitts, MB BCh b, Rachel Y.N. Miest, MD c, Todd B. Nippoldt, MD b, Megha M. Tollefson, MD c, d, ⁎ 
a Mayo Clinic Alix School of Medicine, Rochester, Minnesota
b Department of Endocrinology, Mayo Clinic, Rochester, Minnesota
c Department of Dermatology, Mayo Clinic, Rochester, Minnesota
d Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
∗Correspondence to: Megha M. Tollefson, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905Department of DermatologyMayo Clinic200 First St SWRochesterMN55905
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Reviewed and approved by the Mayo Clinic Institutional Review Board (identification no. 18-005666). |
|
| Reprints not available from the author(s). |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 5
P. 1516-1518 - novembre 2020 Retour au numéro
Article précédent
- Gender and racial underrepresentation in academic dermatology positions in the United States: A retrospective, cross-sectional study from 2007 to 2018
- Justin D. Lu, Sabeen Tiwana, Priya Das, Javed Siddiqi, Faisal Khosa
- Treatment of calcinosis cutis with sodium thiosulfate therapy
- Rachel M. Howard, Gideon P. Smith
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?